Prediction: Lilly Will Trade at $1,200 by Year-End
Investors weigh a bold forecast that Eli Lilly could hit $1,200 by year-end 2026, betting on GLP-1 drugs and a robust...
Discover why dividend ETFs incur fees, including management costs and tracking errors, and how those charges influence your long-term results.
26,393 articlesInvestors weigh a bold forecast that Eli Lilly could hit $1,200 by year-end 2026, betting on GLP-1 drugs and a robust...
Intercontinental Exchange (ICE) and OKX reveal a joint venture to tokenize NYSE-listed assets, with former governor A...
Pennymac confirms it will shutter its Franklin, TN office and reduce staff in its consumer direct lending unit, part ...
Tesla breaches a key price level near $382 as investors weigh margin pressures from tech compression and intensifying...
Iraq signals a possible exit from OPEC, fueling bets that a world rejecting opec controls could unleash softer oil pr...
What happens when AI breakthroughs and high-flying tech bets collide with political markets? This article explains th...
El Salvador’s bitcoin reserve faces renewed IMF scrutiny as market swings test a government crypto policy, raising ac...
Netflix has shifted from rapid growth to a more measured pace. This guide provides a clear framework to consider shou...
The FBI director disclosed a late Strategy stock purchase, prompting questions about STOCK Act timing and potential c...
As Trump escalates public pressure on the Fed, new chair Warsh faces a test of independence. Markets swing while trad...
XRP has climbed over 9% in the past week and now trades near $1.15 after a brief dip to $1.01. Analysts say the token...
Billionaire John Arnold Already backs a major push to study sports betting risks, awarding $2.6 million to 12 univers...